Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

Fig. 2

Expression levels of Maspin post-transfection in bladder cancer T24 and 5637 cells. The mRNA and protein levels of Maspin in bladder cancer T24 and 5637 cells transfected with pcDNA3.1-Maspin or negative control (pcDNA3.1-con) were detected by RT-PCR and western blot. a and b were showed mRNA level of T24 and 5637 cells, respectively. And c and d were showed protein expression level. *P < 0.05. Three independent experiments were performed (n = 3)

Back to article page